XML 82 R70.htm IDEA: XBRL DOCUMENT

List of principal subsidiaries (Tables)

12 Months Ended

Dec. 31, 2022

Disclosure of subsidiaries [abstract]

Disclosure of the principal subsidiaries of the Company

The following list contains the material subsidiaries of the Group at December 31, 2022 and December 31, 2021 are as follows:


Name of subsidiaries		Place of incorporation/ operation		Issued and fully paid share capital		Proportion of nominal value of issue capital held by the Company																Principal activities
						2022								2021
						Directly				Indirectly				Directly				Indirectly
						%				%				%				%
Prenetics Limited		Hong Kong		HK$415,276,716			—				100				—				100			Genetic and diagnostic health testing
Prenetics EMEA Limited		United Kingdom		GBP76,765.81			—				100				—				100			Genetic and diagnostic health testing
ACT Genomics Holdings Company Limited (note 33)		Cayman Islands		$16,713			74.39				—				—				—			Precise cancer genetic testing services

ACT Genomics Co., Ltd.		Taiwan		TWD455,080,000			—				74.33				—				—			Precise cancer genetic testing - services
ACT Genomics (Hong Kong) Limited		Hong Kong		HK$775,000			—				74.39				—				—			Precise cancer genetic testing - services
Sanomics Limited		Hong Kong		HK$500,000			—				74.39				—				—			Precise cancer genetic testing - services
MC Diagnostics Limited		United Kingdom		GBP1,164			—				74.39				—				—			Sales of medical diagnostics products